Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s As
-
AXIL Signs Agreement with Beretta Hellas LTD to Distribute AXIL Hearing Protection and Enhancement Products in Greece
-
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
-
iPower to Participate in the Water Tower Research Fireside Chat Series on April 18
-
C-Bond Systems, Inc. Engages Cervitude Intelligent Relations for Investor Awareness Services
-
3D Systems Announces FDA Clearance for World’s First 3D-Printed PEEK Cranial Implants
-
Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia
-
CONTEXTLOGIC VOTE UPDATE: Less Than 350,000 Shares Needed to Approve the Proposed Transaction with Qoo10
-
Mobile-health Network Solutions Makes History as First APAC Telehealth Company Listed on US Stock Exchange
-
Microbot Medical Shares Status Following Recent Geopolitical Events
-
The United States FDA Awards Orphan Drug Designation (ODD) to NM5072 for Treating Paroxysmal Nocturnal Hemoglobinuria (PNH)
-
Marathon Digital Holdings Appoints Manoj Narender Madnani as Managing Director for EMEA Expansion
-
LiveOne (Nasdaq: LVO) Subsidiary Slacker Radio Hits All Time High Country Music Usage, Helping to Increase Revenue 300% and Driving a Remarkable 800% Increase in Share of Female Country Artists Across
-
Stevie® Awards Honors ValueSelling Associates and Its Clients for Sales & Customer Service
-
US Nuclear’s Unparalleled PFAS Monitoring Products in Spotlight as EPA Sets First-Ever Limits on PFAS
-
The Lee Health Heart Institute Achieves Most Abstract Acceptance at the Annual American College of Cardiology Conference
-
Saratoga Investment Corp. to Report Fiscal Fourth Quarter 2024 Financial Results and Hold Conference Call
-
HeartCore Signs 14th Go IPO Contract
-
Signing Day Sports Announces Appointment of Jeff Hecklinski as President
-
3D Systems Announces FDA Clearance for World’s First 3D-Printed PEEK Cranial Implants
-
Centurion Service Group to auction all assets following the closure of St. Margaret’s Health - Spring Valley f/k/a St. Margaret’s Hospital in Spring Valley, IL
-
Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme
-
Fiverr to Release First Quarter 2024 Results on May 9, 2024
-
PANDORA REDUCES TREASURY SHARES TO LESS THAN 5% OF SHARE CAPITAL
-
Ferrari N.V.: Periodic Report on the Buyback Program
-
PetMeds® Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement
-
KULR Technology Group Announces Appointment of Donna H. Grier to its Board of Directors
-
Sight Machine for Siemens Industrial Edge Brings Manufacturing AI to Factory Automation Systems
-
Transactions in connection with share buyback programme
-
Blue World Acquisition Corporation Postponed the Extraordinary General Meeting to Approve the Business Combination with TOYO Solar Pending A Post-Effective Amendment to The Registration Statement
-
Blue World Acquisition Corporation Postponed the Extraordinary General Meeting to Approve the Business Combination with TOYO Solar Pending A Post-Effective Amendment to The Registration Statement
-
Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights
-
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compare
-
ACV Transportation Expands Services to Vehicles Purchased Outside of the ACV Platform
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – M
-
Microchip Technology Acquires Neuronix AI Labs
-
REPEAT – MEDIA ADVISORY: Press conferences with patients who have been charged user fees of hundreds or even thousands of dollars at for-profit surgery clinics
-
ArcelorMittal's Irina Gorbounova Joins CHAR Tech Board of Directors
-
Altus Group Recognized as “Data Solution of the Year for Real Estate" in 2024 Data Breakthrough Awards
-
ERES REIT Declares April 2024 Monthly Distribution
-
Turning dreams into reality: 1970s-inspired Lachine Hospital Foundation Gala raises $182,830 net to support the modernization and expansion of the Lachine Hospital
-
CAPREIT Announces April 2024 Distribution
-
Cumulus Media Announces Additional Extension of Expiration Time in Exchange Offer and Consent Solicitation Relating to 6.750% Senior Secured First-Lien Notes due 2026
-
Altus Group Recognized as “Data Solution of the Year for Real Estate" in 2024 Data Breakthrough Awards
-
TRIEC Mentoring Partnership Program Celebrates 20th Anniversary and Recognizes Employers and Mentors in Award Recognition Gala
-
ThreeD Capital Inc. and Lophos Holdings Inc. Announce Strategic Partnership
-
ThreeD Capital Inc. Announces Securities Purchase Agreement with Lophos Holdings Inc.
-
Pulmocide Announces Successful Results from the OPERA-S Study: a Phase 2 Safety Study with Inhaled Opelconazole
-
Viracta Therapeutics Announces Positive Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial in Patients with Relapsed or Refractory Epstein-Barr Virus-Positive (EBV+) Peripheral T-Cell Lymphoma
-
London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVI
